Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lung Neoplasms × carfilzomib × Clear all

Sponsor

Conditions

Multiple Myeloma 48 Recurrence 8 Lymphoma 5 Waldenstrom Macroglobulinemia 4 Neoplasms, Plasma Cell 4 Small Cell Lung Carcinoma 3 Ovarian Neoplasms 2 Lymphoma, Non-Hodgkin 2 Kidney Neoplasms 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Sezary Syndrome 1 Salivary Gland Adenoma, Pleomorphic 1 Renal Insufficiency 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia 1 Kidney Failure, Chronic 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

Carboplatin 89 Pemetrexed 65 Paclitaxel 50 Erlotinib Hydrochloride 46 Cisplatin 46 Radiotherapy 45 Docetaxel 37 Gemcitabine 34 Bevacizumab 32 pembrolizumab 25 Nivolumab 23 Radiosurgery 18 Etoposide 18 durvalumab 12 Cetuximab 12 Ipilimumab 11 Albumin-Bound Paclitaxel 10 Vinorelbine 9 Taxes 9 Gefitinib 9 Radiation 8 Magnetic Resonance Spectroscopy 8 osimertinib 7 Specimen Handling 7 Platinum 7 Cyclophosphamide 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 vandetanib 6 epacadostat 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡